Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CNR1 | P21554 | 2/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.42 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.41 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL303162 | 1.00 | TDP1 (0.47) | TDP1LMNACNR1EGFRSOAT2 | |
| SCHEMBL2125298 | 1.00 | TDP1 (0.47) | TDP1LMNACNR1EGFRSOAT2 | |
| SCHEMBL303521 | 1.00 | TDP1 (0.47) | TDP1LMNACNR1EGFRSOAT2 | |
| SCHEMBL302928 | 1.00 | TDP1 (0.47) | TDP1LMNACNR1EGFRSOAT2 | |
| SCHEMBL139446 | 1.00 | TDP1 (0.47) | TDP1LMNACNR1EGFRSOAT2 | |
| SCHEMBL303164 | 1.00 | TDP1 (0.47) | TDP1LMNACNR1EGFRSOAT2 | |
| SCHEMBL304116 | 1.00 | TDP1 (0.47) | TDP1LMNACNR1EGFRSOAT2 | |
| SCHEMBL302694 | 1.00 | TDP1 (0.47) | TDP1LMNACNR1EGFRSOAT2 | |
| SCHEMBL5206775 | 1.00 | TDP1 (0.47) | TDP1LMNACNR1EGFRSOAT2 | |
| SCHEMBL302639 | 1.00 | TDP1 (0.47) | TDP1LMNACNR1EGFRSOAT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103459452-B | Storage-stable polyurethane prepregs made of polyurethane compositions with liquid resin components and molded parts made therefrom | EVONIK DEGUSSA GMBH (DE) | 2016-11-30 | — | — | CN | claimed |
| CN-103459452-A | Storage-stable polyurethane prepregs made of polyurethane compositions with liquid resin components and molded parts made therefrom | EVONIK DEGUSSA GMBH | 2013-12-18 | — | — | CN | claimed |
| EP-2415474-B1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF OPHTHALMIC DISEASES | UBE INDUSTRIES (JP) | 2013-08-28 | — | — | EP | claimed |
| EP-2221308-B1 | BENZAZEPINONE COMPOUND | UBE INDUSTRIES (JP) | 2013-07-10 | — | — | EP | claimed |
| US-8377922-B2 | Benzazepinone compound | UBE INDUSTRIES, LTD. (JP) | 2013-02-19 | — | — | US | claimed |
| US-20120095215-A1 | MEDICAL COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF EYE DISEASES | UBE INDUSTRIES, LTD. (JP) | 2012-04-19 | — | — | US | claimed |
| EP-2415474-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF OPHTHALMIC DISEASES | Ube Industries, Ltd. (JP) | 2012-02-08 | — | — | EP | claimed |
| US-20100249396-A1 | BENZAZEPINONE COMPOUND | UBE INDUSTRIES, LTD. (JP) | 2010-09-30 | — | — | US | claimed |
| EP-2221308-A1 | BENZAZEPINONE COMPOUND | Ube Industries, Ltd. (JP) | 2010-08-25 | — | — | EP | claimed |
| US-5145591-A | Oil, nonseparating | NIPPON OIL CO., LTD. (JP) | 1992-09-08 | — | — | US | claimed |
| EP-3604319-B1 | CATIONIC RUTHENIUM COMPLEX, AND PRODUCTION METHOD THEREFOR AND USE THEREOF | TAKASAGO PERFUMERY CO LTD (JP) | 2023-06-21 | — | — | EP | disclosed |
| CN-110475783-B | Cationic ruthenium complex, preparation method and application thereof | 高砂香料工业株式会社 | 2022-10-21 | — | — | CN | disclosed |
| US-11325933-B2 | Cationic ruthenium complex, and production method therefor and use thereof | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2022-05-10 | — | — | US | disclosed |
| EP-3992288-A1 | CARBOXYLATED 2'-AMINO-LNA NUCLEOTIDES AND OLIGONUCLEOTIDES COMPRISING THE SAME | BioNTech Delivery Technologies GmbH (DE) | 2022-05-04 | — | — | EP | disclosed |
| US-11152208-B2 | Semiconductor film, method of forming semiconductor film, complex compound for doping, and method of doping | FLOSFIA INC. (JP) | 2021-10-19 | — | — | US | disclosed |
| WO-1984004092-A1 | (HYDROCARBYLTHIO)PHENOLS AND THEIR PREPARATION | ETHYL CORP (US) | 1984-10-25 | — | — | WO | disclosed |
| EP-0122203-A1 | (Hydrocarbylthio)phenols and their preparation | ETHYL CORPORATION (US) | 1984-10-17 | — | — | EP | disclosed |
| EP-0107805-A2 | Mixed 2,2,6,6-tetramethyl piperidinyl carboxylic acid ester and amide light stabilizers and stabilized synthetic polymers | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1984-05-09 | — | — | EP | disclosed |
| US-4171424-A | Polyesters containing units derived from metal salts of N-hydroxyalkylated branched α-aminoacids | CIBA-GEIGY CORPORATION (US) | 1979-10-16 | — | — | US | disclosed |
| US-4093639-A | HEAT RESISTANCE | CIBA-GEIGY CORPORATION (US) | 1978-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120095215-A1 | MEDICAL COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF EYE DISEASES | VEGFA, UACA, PGF | TDP1 4753/4885LMNA 2371/4885CNR1 176/4885 |
| US-20100249396-A1 | BENZAZEPINONE COMPOUND | KCNJ11, KCNJ1, KCNJ2 | TDP1 4053/4885LMNA 1200/4885CNR1 9/4885 |
| US-11325933-B2 | Cationic ruthenium complex, and production method therefor and use thereof | NOTUM, POR, ADH1A | TDP1 1474/4885LMNA 4432/4885CNR1 107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.